Belvedere Research
For CompaniesAboutRequest Coverage

Data page

Small-Cap Healthcare Companies

Healthcare and biotechnology issuers screened by SEC revenue, not by licensed market capitalization.

Belvedere does not currently display licensed market capitalization. The screens below use latest reported quarterly revenue from SEC XBRL as a disclosure-size proxy, not as a market-cap category. On this page, the small-cap proxy is latest quarterly revenue from $5 million through $250 million.

Data dateSep 21, 2026
SourceSEC EDGAR XBRL
Market capNot used
Document typeData page

Is this a list of small-cap healthcare stocks to buy?

No. It is a disclosure-size universe table with sourced financial facts.

How is small-cap defined here?

Latest quarterly SEC revenue between $5 million and $250 million. Licensed market capitalization is not used.

Public companies in the Belvedere universe
CompanyTickerIndustryRevenueGrowthBelvedere FCFLatest filingResearch
Amphastar Pharmaceuticals, Inc.Nasdaq: AMPHAMPHPharmaceutical Preparations$183.9M+5.4%—10-Q · Aug 6, 2026Universe
ANGIODYNAMICS INCNasdaq: ANGOANGOSurgical & Medical Instruments & Apparatus$78.4M+8.9%—4 · Jul 31, 2026Universe
AtriCure, Inc.Nasdaq: ATRCATRCSurgical & Medical Instruments & Apparatus$153.6M+12.8%—10-Q · Jul 27, 2026Universe
CERUS CORPNasdaq: CERSCERSSurgical & Medical Instruments & Apparatus$57.4M+9.5%—10-Q · Jul 30, 2026Universe
Pacira BioSciences, Inc.Nasdaq: PCRXPCRXPharmaceutical Preparations$192.4M+6.2%—10-Q · Aug 4, 2026Universe
ROGERS CORPNYSE: ROGROGPlastic Materials, Synth Resins & Nonvulcan Elastomers$200.5M+5.2%$1.1M10-Q · Jul 29, 2026Universe
SUPERNUS PHARMACEUTICALS, INC.Nasdaq: SUPNSUPNPharmaceutical Preparations$219.1M+32.4%—10-Q · Aug 3, 2026Universe

7 of 7 issuers in the small-cap healthcare revenue proxy.

Fastest-growing in this screen

  • 1. SUPERNUS PHARMACEUTICALS, INC. (SUPN) · +32.4%
  • 2. AtriCure, Inc. (ATRC) · +12.8%
  • 3. CERUS CORP (CERS) · +9.5%
  • 4. ANGIODYNAMICS INC (ANGO) · +8.9%
  • 5. Pacira BioSciences, Inc. (PCRX) · +6.2%
  • 6. Amphastar Pharmaceuticals, Inc. (AMPH) · +5.4%
  • 7. ROGERS CORP (ROG) · +5.2%

Research Radar (subset)

  • Amphastar Pharmaceuticals, Inc. (AMPH) — Revenue: +5.4%
  • Amphastar Pharmaceuticals, Inc. (AMPH) — Revenue acceleration: +5.1 pp
  • Amphastar Pharmaceuticals, Inc. (AMPH) — Margin change: $0.508
  • Amphastar Pharmaceuticals, Inc. (AMPH) — Cash: $223.6M
  • Amphastar Pharmaceuticals, Inc. (AMPH) — Share count: $42.5M
  • Pacira BioSciences, Inc. (PCRX) — Revenue: +6.2%

Methodology

Universe, eligibility, and limitations

Eligibility

  • Belvedere operating-company universe
  • Healthcare or Biotechnology sector mapping
  • Latest quarterly revenue between $5 million and $250 million

Limitations

  • Not a Russell or S&P small-cap index
  • No recommendations
  • FCF is a Belvedere calculation when shown
Micro-cap healthcare companiesSmall-cap equity researchHealthcare growth rankingHealthcare industryWhat is a micro-cap company?

Frequently asked questions

Is this a list of small-cap healthcare stocks to buy?
No. It is a disclosure-size universe table with sourced financial facts.
How is small-cap defined here?
Latest quarterly SEC revenue between $5 million and $250 million. Licensed market capitalization is not used.
How does this differ from the healthcare growth ranking?
This page lists eligible issuers. The healthcare revenue-growth ranking orders issuers that also have comparable year-over-year revenue by a published formula.

For public companies

Request research coverage

Compensation does not purchase ranking placement or research conclusions.

Request Coverage